Our Website Sponsors
- email
Thanks for emailing that article!
-
A special "thank you" to our website sponsors.
We appreciate support from corporations and foundations who believe in our mission to educate glaucoma patients and speed a cure. Sponsor opinions are not reflected on our website.
iScience
iScience is leading the discovery and development of the product platforms used in Interventional Ophthalmology for sight-threatening ocular conditions. Utilizing iScience’s advanced imaging and catheter technologies, interventional ophthalmologists can deliver precise, site-specific therapies for the eye. One site-specific therapy is Canaloplasty, the first and only microcatheter-based procedure that safely reduces intraocular pressure (IOP) and dependence on medications in primary open-angle glaucoma patients. Canaloplasty is FDA approved and reimbursed by Medicare. Over 15,000 procedures have been performed to date.
Lumenis Ltd.
Lumenis Ltd., a global leader in medical and aesthetic lasers and light-based technology, is dedicated to improving people's lives with advanced technological solutions for treating their medical and cosmetic conditions. Lumenis developed and markets the Selective Laser Trabeculoplasty (SLT) technology for managing open-angle glaucoma. SLT treatments have helped preserve vision for hundreds of thousands of glaucoma patients worldwide.
Last reviewed on January 05, 2012
